These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28397050)

  • 1. Waist circumference-dependent peripheral monocytes change after gliclazide treatment for Chinese type 2 diabetic patients.
    Li Q; Yu HY; Chen M; Jiang F; Zhou J; Bao YQ; Hu C; Jia WP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):204-209. PubMed ID: 28397050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus.
    Erem C; Ozbas HM; Nuhoglu I; Deger O; Civan N; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):295-302. PubMed ID: 24710641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM).
    Sliwinska A; Blasiak J; Kasznicki J; Drzewoski J
    Chem Biol Interact; 2008 Jun; 173(3):159-65. PubMed ID: 18485337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medication of the month. Gliclazide modified release (Uni Diamicron)].
    Scheen AJ
    Rev Med Liege; 2003 Oct; 58(10):641-5. PubMed ID: 14677526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.
    Guillausseau PJ; Greb W
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):133-7. PubMed ID: 11353879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.
    Chen LL; Yu F; Zeng TS; Liao YF; Li YM; Ding HC
    Eur J Pharmacol; 2011 Jun; 659(2-3):296-301. PubMed ID: 21453695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multicenter clinic study of slow-release-gliclazide in type 2 diabetes mellitus].
    Jia WP; Ning G; Gao X; Yan L; Yang HZ; Li M; Hong J; Lu ZQ; Cheng H; Qi YQ; Li ZW; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2636-9. PubMed ID: 16321325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
    Jennings PE; Belch JJ
    Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal insulin response to short-term intense exercise is abolished in Type 2 diabetic patients treated with gliclazide.
    Szewieczek J; Dulawa J; Strzałkowska D; Batko-Szwaczka A; Hornik B
    J Diabetes Complications; 2009; 23(6):380-6. PubMed ID: 18394931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation.
    Frey N; Laveille C; Paraire M; Francillard M; Holford NH; Jochemsen R
    Br J Clin Pharmacol; 2003 Feb; 55(2):147-57. PubMed ID: 12580986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy of type 2 diabetes with once-daily gliclazide modified release in primary care.
    Ramachandran A
    Diabetes Res Clin Pract; 2003 Oct; 62(1):63-4. PubMed ID: 14581160
    [No Abstract]   [Full Text] [Related]  

  • 15. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast.
    Zargar AH; Siraj M; Jawa AA; Hasan M; Mahtab H
    Int J Clin Pract; 2010 Jul; 64(8):1090-4. PubMed ID: 20455956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus].
    Li GW; Pan CY; Gao Y; Yuan SY; Yang WY; Xing XY; Tian H; Guo XH; Li HB
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):510-4. PubMed ID: 15312405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects.
    Schernthaner G
    Metabolism; 2003 Aug; 52(8 Suppl 1):29-34. PubMed ID: 12939737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
    Strojek K; Bresler M; Gumprecht J; Grzeszczak W; Trautsolt W
    Pol Arch Med Wewn; 1993 Apr; 89(4):315-9. PubMed ID: 8351232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
    Wascher TC; Boes U
    Clin Physiol Funct Imaging; 2005 Jan; 25(1):40-6. PubMed ID: 15659079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A weekly administered sustained-release growth hormone reduces visceral fat and waist circumference in abdominal obesity.
    Hong JW; Park JK; Lim CY; Kim SW; Chung YS; Kim SW; Lee EJ
    Horm Metab Res; 2011 Dec; 43(13):956-61. PubMed ID: 22072433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.